TG Therapeutics Appoints CCO

Adam Waldman joins the company with over two decades of experience

TG Therapeutics has appointed Adam Waldman as chief commercial officer.  Mr. Waldman was most recently the head of US Hematology-Oncology Marketing at Celgene Corporation, and has an extensive track record of successfully launching multiple brands.  Michael S. Weiss, executive chairman and chief executive officer, said, “We are extremely pleased to welcome Adam to the TG Therapeutics team. He brings extensive experience to the company and as we move towards commercialization he will be an ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters